FA
IONS icon

FDx Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

FDx Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,575
Closed -$206K – 848
2022
Q1 		$206K Buy
+5,575
New +$182K 0.01% 788
2021
Q4 		– Sell
-7,507
Closed -$252K – 867
2021
Q3 		$252K Sell
7,507
-869
-10% -$32.7K 0.01% 718
2021
Q2 		$334K Buy
8,376
+658
+9% +$25.8K 0.01% 625
2021
Q1 		$347K Buy
7,718
+534
+7% +$29.8K 0.01% 582
2020
Q4 		$406K Buy
7,184
+1,024
+17% +$51K 0.02% 490
2020
Q3 		$292K Buy
6,160
+685
+13% +$38.1K 0.01% 492
2020
Q2 		$323K Sell
5,475
-252
-4% -$14K 0.02% 431
2020
Q1 		$271K Sell
5,727
-696
-11% -$38.8K 0.02% 410
2019
Q4 		$388K Buy
6,423
+287
+5% +$17.1K 0.02% 417
2019
Q3 		$368K Buy
6,136
+351
+6% +$22.9K 0.03% 423
2019
Q2 		$372K Buy
5,785
+1,269
+28% +$89.7K 0.01% 561
2019
Q1 		$367K Sell
4,516
-1,013
-18% -$65.3K 0.01% 543
2018
Q4 		$299K Sell
5,529
-676
-11% -$34.5K 0.02% 413
2018
Q3 		$320K Sell
6,205
-119
-2% -$5.59K 0.01% 673
2018
Q2 		$264K Buy
6,324
+760
+14% +$33.7K 0.01% 767
2018
Q1 		$245K Sell
5,564
-138
-2% -$7.01K 0.01% 1061
2017
Q4 		$287K Buy
5,702
+262
+5% +$14.4K 0.01% 1059
2017
Q3 		$276K Buy
5,440
+168
+3% +$8.8K 0.01% 1080
2017
Q2 		$268K Buy
+5,272
New +$245K 0.01% 1022

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

FDx Advisors's IONS Position: Q2 2022 in Review

FDx Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2022, closing a stake of 5,575 shares — an estimated $206K sold.

FDx Advisors first reported a position in IONS in Q2 2017 and held it in 19 quarters. The position peaked at $406K in Q4 2020. 349 funds tracked by Wall St. Rank hold IONS as of Q2 2022.

  • FDx Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • FDx Advisors sold 5,575 Ionis Pharmaceuticals shares in Q2 2022, an estimated $206K.
  • FDx Advisors first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 19 quarters.
  • FDx Advisors's Ionis Pharmaceuticals position peaked at $406K in Q4 2020.
  • 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2022.

Based on FDx Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.